EDGAR Filing Documents for 0001654954-17-009052

Form 8-K - Current report:

SEC Accession No. 0001654954-17-009052

Filing Date

2017-10-02

Accepted

2017-10-02 17:30:35

Documents

Period of Report

2017-09-26

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	CURRENT REPORT	mdit8k_sep262017.htm	8-K	53712
2	SECURITIES PURCHASE AGREEMENT GPB MEDITE	ex10-1.htm	EX-10.1	251429
3	CONVERTIBLE NOTE MEDITE GPB	ex10-2.htm	EX-10.2	165569
4	SECURITY AGREEMENT - MEDITE GPB	ex10-3.htm	EX-10.3	170404
5	WARRANT MEDITE GPB	ex10-4.htm	EX-10.4	109531
6	REGISTRATION RIGHTS AGREEMENT	ex10-5.htm	EX-10.5	188916
7	SUBORDINATED CREDITOR PURCHASE AGREEMENT	ex10-6.htm	EX-10.6	260005
8	SUBORDINATED NOTE MEDITE GPB MEDITE	ex10-7.htm	EX-10.7	162947
9	SUBORDINATED SECURITY AGREEMENT	ex10-8.htm	EX-10.8	181914
10	WARRANT MEDITE SUBDEBT	ex10-9.htm	EX-10.9	107751
11	GUARANTY OF OBLIGATION - MEDITE-GPB	ex10-10.htm	EX-10.10	118470
12	SUBORDINATED GUARANTY OF OBLIGATION	ex10-11.htm	EX-10.11	142296
13	MEDITE INTERCREDITOR AND SUBORDINATORS	ex10-12.htm	EX-10.12	113155
	Complete submission text file	0001654954-17-009052.txt		2027744

Mailing Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610

Business Address 414 NORTH ORLEANS STREET SUITE 502 CHICAGO IL 60610 4078490290

Medite Cancer Diagnostics, Inc. (Filer) CIK: 0000075439 (see all company filings)